Last Updated on October 10, 2024 by The Health Master
Bristol Myers Squibb said on Friday that the U.S. Food and Drug Administration (USFDA) had approved the expanded use of its cancer drug Opdivo along with chemotherapy as a first-line treatment for patients with an aggressive form of lung cancer.
The approval was based on data from a late-stage study showing the drug along with chemotherapy improved event-free survival and pathologic complete response compared to chemotherapy alone in patients with resectable non-small cell lung cancer, the drugmaker said.
Non-small cell lung cancer is the most common form of lung cancer, accounting for about 85% of the estimated 2.2 million new cases of lung cancer diagnosed each year worldwide, according to the World Health Organization.
Opdivo, Bristol’s flagship cancer drug that was first approved in 2014, brought in $1.99 billion in sales during company’s last reported quarter.
The drug is used in use in patients with several types of cancer including bladder, lung, blood, head and neck and advanced melanoma. It belongs to a class of drugs designed to help the body’s immune system fight cancer by blocking a protein called Programmed cell death protein 1 (PD-1)
USFDA gives nod to Lupin for generic Jublia topical solution
USFDA gives nod to Lupin for Sevelamer Hydrochloride Tablets, 800 mg
USFDA approves this drug for bone marrow cancer treatment
USFDA gives nod to Unichem Laboratories for Divalproex Sodium
USFDA approves this drug for all heart patients to cut death, hospitalization risk
USFDA gives nod to Zydus to market Dapagliflozin tablets
Govt releases draft Unani Pharmacopoeia of India
USFDA declines pediatric EUA for vaccine Covaxin
NPPA cancels study access of medicine at affordable prices
WHO updates its treatment guidelines to include Molnupiravir
USFDA gives nod to Lupin for generic Jublia topical solution
Govt listed 213 drugs for which procurement agencies could not find local manufacturers
USFDA gives nod to Lupin for Sevelamer Hydrochloride Tablets, 800 mg
USFDA declines to approve Gilead’s HIV drug on this concern
Why these Pharma Companies are realigning their India operations
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
